Document is current
Any future updates will be listed below
-
Authors
McElroy, Joseph P.
Song, Min-Ae
Barr, John R.
Gardner, Michael S.
Kinnebrew, Garret
Kuklenyik, Zsuzsanna
Kusovschi, Jennifer D.
Rees, Jon C.
Blount, Benjamin C.
Tsai, MuChun
Wewers, Mark D
Kamel, Sahar
Reisinger, Sarah A.
Singh, Amarnath
Weng, Daniel Y.
Shields, Peter G.
-
Funding
Funding for this research was provided by:
OSU Wexner Medical Center and College of Medicine
OSU pelotonia intramural research funds
OSU college of public health
National Cancer Institute (P30 CA016058)
Center for Tobacco Products (P50CA180908)
National Center for Advancing Translational Sciences (UL1TR001070)
- License Information
-
More Information
Article History
Received: 6 January 2025
Accepted: 1 May 2025
First Online: 20 May 2025
Declarations
:
: The study was approved by The OSU Institutional Review Board (OSU-2015 C0088) and is registered on Clinicaltrials.gov (NCT02596685). Informed consent was obtained from all participants.
: Not Applicable
: P.G. Shields has provided expert testimony for law firms representing plaintiffs in tobacco litigation. No potential conflicts of interest were disclosed by the remaining co-authors.
